Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001968410 | SCV002239918 | uncertain significance | Autosomal dominant limb-girdle muscular dystrophy type 1G | 2021-07-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Not Available"). This variant has not been reported in the literature in individuals affected with HNRNPDL-related conditions. The frequency data for this variant in the population databases is not available, as this variant may be reported as separate entries in the ExAC database. This sequence change replaces glutamic acid with isoleucine at codon 272 of the HNRNPDL protein (p.Glu272Ile). The glutamic acid residue is highly conserved and there is a moderate physicochemical difference between glutamic acid and isoleucine. |
Revvity Omics, |
RCV001968410 | SCV003808709 | uncertain significance | Autosomal dominant limb-girdle muscular dystrophy type 1G | 2019-12-16 | criteria provided, single submitter | clinical testing |